Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jacques Tortochaux"'
Autor:
Pierre Verrelle, Christian Domenge, Atoussa Etessami, Michel Lapeyre, François Janot, Jacques Tortochaux, Antoine Lusinchi, Yun G. Tao, Pierre Blanchard, Stéphane Temam, Pierre Wibault, Lionel Geoffrois, Murielle Ducourtieux, Jean Bourhis, Anne Auperin
Publikováno v:
Radiotherapy and Oncology. 100:56-61
Background The objective was to evaluate the efficacy of a strong increase of the dose-intensity of concomitant radio-chemotherapy (RT-CT) in patients with far advanced non metastatic HNSCC. Methods Eligible patients had N3 disease (UICC 1997) and th
Autor:
C. Alzieu, Alain Ramaioli, Nicolas Magné, Emmanuel Chamorey, Pierre Chauvel, Hang Seng, Frederic Peyrade, Gilles Calais, Bernard Gery, Maurice Schneider, Pierre-Yves Marcy, Sylvain Bourdin, José Santini, Claire Lemanski, François Demard, Jacques Tortochaux, René-Jean Bensadoun, Gilles Poissonnet, Olivier Dassonville, Karen Benezery, Jacques Vallicioni
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 64:983-994
Unresectable carcinomas of the oropharynx and hypopharynx still have a poor long-term prognosis. Following a previous phase II study, this phase III multicenter trial was conducted between November 1997 and March 2002.Nontreated, strictly unresectabl
Autor:
Hernán Cortés-Funes, Jose Baselga, Jean Bourhis, Andreas Harstrick, Nadia Amellal, Pere Gascón, Jacques Tortochaux, André Eckardt, Ricardo Hitt, Jose Manuel Trigo
Publikováno v:
Journal of Clinical Oncology. 23:5568-5577
Purpose To evaluate the efficacy and safety of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory recurrent or metastatic squamous cell carcinoma
Autor:
Gilles Calais, Etienne Bardet, Jacques Tortochaux, Marc Alfonsi, Jean Bourhis, H. Auvray, B. Rhein, Yooye Tao Kong Man, Christian Sire, Pascal Garaud
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 58:161-166
Purpose We designed a prospective Phase II clinical trial to evaluate the addition of weekly chemotherapy using Docetaxel during standard radiation therapy in patients with Stages III and IV oropharynx carcinoma. Methods A total of 63 patients have b
Autor:
Didier Blaise, Dominique Maraninchi, Philippe Chollet, J. Fleury, J. P. Lamagnere, Philippe Travade, Patrice Viens, R. Plagne, Claude Linassier, Michel Legros, Claude Dionet, Philippe Colombat, Jacques Tortochaux, Hervé Curé
Publikováno v:
Leukemia & Lymphoma. 20:259-266
We report the experience of three French centres which evaluated high-dose therapy (HDT) as consolidation therapy for poor prognosis Hodgkin's disease (HD). From March 1986 to April 1990, 23 consecutive patients with poor prognosis stage IV HD underw
Autor:
R. Plagne, Philippe Chollet, Claude Dionet, Ernest Belembaogo, Françoise Tavernier, Jacques Tortochaux, Hervé Curé, Michel Legros, Philippe Travade, J. Fleury, Fabrice Kwiatkowski, Paule Condat
Publikováno v:
Leukemia & Lymphoma. 15:419-432
Most patients with Hodgkin's disease (HD) are cured with chemotherapy and/or radiotherapy. However, half of those with advanced stage disease (IIIB, IV) do not respond adequately to treatment or relapse. Salvage therapy used in such cases gives from
Autor:
P. Bontemps, Yungan Tao, Elodie Tournay, Etienne Bardet, Nicolas Daly-Schveitzer, Antoine Lusinchi, Jean Bourhis, Ellen Benhamou, Jacques Tortochaux, François Lesaunier, Philippe Maingon, Michel Lapeyre, Gilles Calais, François Janot, Pierre Verrelle
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 100(1)
Purpose This randomized phase III trial investigated the potential benefit of concurrent re-irradiation, fluorouracil and hydroxyurea versus methotrexate for patients treated with palliative intent for recurrent or second primary head and neck squamo
Autor:
Jacques Tortochaux, Yoann Pointreau, Marc Alfonsi, Gilles Calais, Sophie Chapet, C. Tuchais, Christian Sire, Sandrine Faivre, Pascal Garaud, Stephane Guerrif
Publikováno v:
Journal of the National Cancer Institute. 101(7)
BACKGROUND Chemotherapy with cisplatin (P) and 5-fluorouracil (F) followed by radiotherapy in patients who respond to chemotherapy is an alternative to total laryngectomy for patients with locally advanced larynx and hypopharynx cancer. Data suggest
Autor:
Frédérique Penault-Llorca, Marianne Leheurteur, Philippe Chollet, Catherine Abrial, Inès Raoelfils, Marie-Ange Mouret-Reynier, Xavier Durando, Hervé Curé, P. Gimbergues, Jacques Tortochaux
Publikováno v:
The oncologist. 12(4)
Recent trials of induction chemotherapy in bulky operable breast cancer have shown much higher pathological complete response (pCR) rates with trastuzumab-driven combinations. However, it is useful to take into account the specific chemosensitivity o
Autor:
Christian Sire, Etienne Bardet, Gilles Calais, Michel Lapeyre, P. Bergerot, M. Rives, B. Rhein, Jacques Tortochaux, Jean-Henri Bourhis, Marc Alfonsi, B. Desprez
Publikováno v:
Seminars in oncology. 31(6)
In the early 1990s, when conventional radiotherapy (RT) was the standard of care in patients with locally advanced head and neck squamous cell carcinoma (HNSCC), two main options were being tested to improve the efficacy and the therapeutic ratio of